Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 25.3x - 28.0x | 26.7x |
| Selected Fwd EBIT Multiple | 16.6x - 18.3x | 17.4x |
| Fair Value | ﷼15.94 - ﷼17.65 | ﷼16.79 |
| Upside | -7.9% - 2.0% | -2.9% |
| Benchmarks | Ticker | Full Ticker |
| National Medical Care Company | 4005 | SASE:4005 |
| Naba Al Saha Medical Services Company | 9546 | SASE:9546 |
| Al Hammadi Holding Company | 4007 | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 4013 | SASE:4013 |
| Saudi Chemical Holding Company | 2230 | SASE:2230 |
| Twareat Medical Care Company | 9627 | SASE:9627 |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| 4005 | 9546 | 4007 | 4013 | 2230 | 9627 | ||
| SASE:4005 | SASE:9546 | SASE:4007 | SASE:4013 | SASE:2230 | SASE:9627 | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 23.6% | NM- | 16.3% | 22.1% | 28.9% | NM- | |
| 3Y CAGR | 15.7% | -3.2% | 31.9% | 17.1% | 45.3% | NM- | |
| Latest Twelve Months | 11.2% | -42.4% | -5.5% | 14.8% | 1.3% | 59.7% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 19.8% | 21.8% | 21.8% | 20.6% | 5.4% | 13.3% | |
| Prior Fiscal Year | 22.8% | 24.0% | 29.1% | 22.0% | 6.5% | 10.2% | |
| Latest Fiscal Year | 19.7% | 13.0% | 26.5% | 21.0% | 6.8% | 13.2% | |
| Latest Twelve Months | 20.2% | 13.0% | 26.1% | 19.9% | 6.6% | 13.2% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.27x | 3.50x | 4.46x | 7.66x | 1.17x | 3.52x | |
| EV / LTM EBITDA | 21.0x | 19.8x | 13.4x | 32.1x | 15.8x | 23.7x | |
| EV / LTM EBIT | 26.1x | 26.9x | 17.1x | 38.4x | 17.9x | 26.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | 17.1x | 26.1x | 38.4x | ||||
| Historical EV / LTM EBIT | 26.8x | 26.8x | 26.8x | ||||
| Selected EV / LTM EBIT | 25.3x | 26.7x | 28.0x | ||||
| (x) LTM EBIT | 25 | 25 | 25 | ||||
| (=) Implied Enterprise Value | 640 | 673 | 707 | ||||
| (-) Non-shareholder Claims * | (11) | (11) | (11) | ||||
| (=) Equity Value | 628 | 662 | 696 | ||||
| (/) Shares Outstanding | 40.0 | 40.0 | 40.0 | ||||
| Implied Value Range | 15.71 | 16.55 | 17.40 | ||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 15.71 | 16.55 | 17.40 | 17.30 | |||
| Upside / (Downside) | -9.2% | -4.3% | 0.6% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4005 | 9546 | 4007 | 4013 | 2230 | 9627 | |
| Enterprise Value | 7,802 | 680 | 5,221 | 96,449 | 7,637 | 703 | |
| (+) Cash & Short Term Investments | 477 | 43 | 291 | 2,185 | 143 | 2 | |
| (+) Investments & Other | 0 | 2 | 140 | 473 | 0 | 0 | |
| (-) Debt | (454) | (89) | (307) | (9,034) | (1,722) | (13) | |
| (-) Other Liabilities | 0 | 0 | 0 | (472) | (13) | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 7,825 | 635 | 5,345 | 89,600 | 6,046 | 692 | |
| (/) Shares Outstanding | 44.7 | 10.5 | 160.0 | 350.0 | 843.2 | 40.0 | |
| Implied Stock Price | 175.10 | 60.50 | 33.41 | 256.00 | 7.17 | 17.30 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 175.10 | 60.50 | 33.41 | 256.00 | 7.17 | 17.30 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |